Early use of remote dielectric sensing after hospitalization to reduce heart failure readmissions
Lala, Anuradha (Icahn School of Medicine at Mount Sinai)
Barghash, Maya H. (Icahn School of Medicine at Mount Sinai)
Giustino, Gennaro (Icahn School of Medicine at Mount Sinai)
Alvarez-Garcia, Jesus (Institut d'Investigació Biomèdica Sant Pau)
Konje, Swiri (St. Luke's Hospital)
Parikh, Aditya (Icahn School of Medicine at Mount Sinai)
Ullman, Jennifer (Icahn School of Medicine at Mount Sinai)
Keith, Brendan (Icahn School of Medicine at Mount Sinai)
Donehey, John (Icahn School of Medicine at Mount Sinai)
Mitter, Sumeet S. (Icahn School of Medicine at Mount Sinai)
Trivieri, Maria Giovanna (Icahn School of Medicine at Mount Sinai)
Contreras, Johanna P. (Institut d'Investigació Biomèdica Sant Pau)
Burkhoff, Daniel (Cardiovascular Research Foundation)
Moss, Noah (Icahn School of Medicine at Mount Sinai)
Mancini, Donna M. (Icahn School of Medicine at Mount Sinai)
Pinney, Sean P. (University of Chicago Medicine, Duchossois Center for Advanced Medicine (DCAM))
Universitat Autònoma de Barcelona

Data:	2020
Resum:	Readmission after hospitalization for acute decompensated heart failure (HF) remains a major public health problem. Use of remote dielectric sensing (ReDS) to measure lung water volume allows for an objective assessment of volume status and may guide medical optimization for HF. We hypothesized that the use of ReDS would lower 30 day readmission in patients referred to rapid follow-up (RFU) clinic after HF discharge. We conducted a retrospective analysis of the use of ReDS for patients scheduled for RFU within 10 days post-discharge for HF at Mount Sinai Hospital between 1 July 2017 and 31 July 2018. Diuretics were adjusted using a pre-specified algorithm. The association between use of ReDS and 30 day readmission was evaluated. A total of 220 patients were included. Mean age was 62. 9 ± 14. 7 years, and 36. 4% were female. ReDS was performed in 80 (36. 4%) and led to medication adjustment in 52 (65%). Use of ReDS was associated with a lower rate of 30 day cardiovascular readmission [2. 6% vs. 11. 8%, hazard ratio (HR): 0. 21; 95% confidence interval (CI): 0. 05-0. 89; P = 0. 04] and a trend towards lower all-cause readmission (6. 5% vs. 14. 1%, HR: 0. 43; 95% CI: 0. 16-1. 15; P = 0. 09) as compared with patients without a ReDS assessment. ReDS-guided HF therapy during RFU after HF hospitalization may be associated with lower risk of 30 day readmission.
Drets:	Aquest document està subjecte a una llicència d'ús Creative Commons. Es permet la reproducció total o parcial, la distribució, la comunicació pública de l'obra i la creació d'obres derivades, sempre que no sigui amb finalitats comercials, i sempre que es reconegui l'autoria de l'obra original.
Llengua:	Anglès
Document:	Article ; recerca ; Versió publicada
Matèria:	Heart failure ; Readmissions ; Remote dielectric sensing ; Congestion
Publicat a:	ESC Heart Failure, Vol. 8 (december 2020) , p. 1047-1054, ISSN 2055-5822

DOI: 10.1002/ehf2.13026
PMID: 33336881

8 p, 2.6 MB

El registre apareix a les col·leccions:
Documents de recerca > Documents dels grups de recerca de la UAB > Centres i grups de recerca (producció científica) > Ciències de la salut i biociències > Institut de Recerca Sant Pau
Articles > Articles de recerca
Articles > Articles publicats